These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3779385)

  • 1. Unilateral, intranigral infusions of amphetamine produce differential, bilateral changes in unit activity and extracellular levels of ascorbate in the neostriatum of the rat.
    Wilson RL; Kamata K; Wightman RM; Rebec GV
    Brain Res; 1986 Oct; 384(2):342-7. PubMed ID: 3779385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop.
    Pierce RC; Clemens AJ; Grabner CP; Rebec GV
    J Neurochem; 1994 Oct; 63(4):1499-507. PubMed ID: 7931303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat.
    Wilson RL; Wightman RM
    Brain Res; 1985 Jul; 339(2):219-26. PubMed ID: 4027622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine.
    White LK; Maurer M; Kraft ME; Oh C; Rebec GV
    Pharmacol Biochem Behav; 1990 Jul; 36(3):485-9. PubMed ID: 2377651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent biphasic alterations in the spontaneous activity of neurons in the rat neostriatum produced by d-amphetamine and methylphenidate.
    Rebec GV; Segal DS
    Brain Res; 1978 Jul; 150(2):353-66. PubMed ID: 567085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum.
    Wilson RL; Kamata K; Bigelow JC; Rebec GV; Wightman RM
    Brain Res; 1986 Apr; 370(2):393-6. PubMed ID: 3518863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
    Pierce RC; Rebec GV
    Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects in the rat after acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sirinathsinghji DJ
    Brain Res; 1985 Jul; 339(2):366-70. PubMed ID: 3928091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltammetry in unanesthetized rat: increases of striatal dopamine turnover after unilateral haloperidol injection into the substantia nigra.
    Kato T; Ishii K; Ikeda M
    Neurosci Lett; 1984 Sep; 50(1-3):263-7. PubMed ID: 6493630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pulse voltammetry: simultaneous in vivo measurement of ascorbic acid, catechols and 5-hydroxyindoles in the rat striatum.
    Crespi F; Sharp T; Maidment NT; Marsden CA
    Brain Res; 1984 Nov; 322(1):135-8. PubMed ID: 6083820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats.
    Yount SE; Kraft ME; Pierce RC; Langley PE; Rebec GV
    Life Sci; 1991; 49(17):1237-44. PubMed ID: 1943438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.
    Miele M; Mura MA; Enrico P; Esposito G; Serra PA; Migheli R; Zangani D; Miele E; Desole MS
    Br J Pharmacol; 2000 Feb; 129(3):582-8. PubMed ID: 10711358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transport and turnover of phospholipids in the rat nigrostriatal system: effects of d-amphetamine and haloperidol.
    Hitzemann R; Loh H
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):209-28. PubMed ID: 6122239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopaminergic agents on levels of dynorphin1-8 in rat striatum.
    Peterson MR; Robertson HA
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):725-8. PubMed ID: 6152345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic and neostriatal neurons: dose-dependent changes in sensitivity to amphetamine following long-term treatment.
    Kamata K; Rebec GV
    Neuropharmacology; 1983 Dec; 22(12A):1377-82. PubMed ID: 6664466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the mechanism of d-amphetamine-and apomorphine-induced changes of ascorbic acid catabolism in discrete brain areas of the rat.
    Desole MS; Miele M; Esposito G; Enrico P; De Natale G; Miele E
    Pharmacol Res; 1991 Apr; 23(3):295-306. PubMed ID: 2068053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum.
    Basse-Tomusk A; Rebec GV
    Pharmacol Biochem Behav; 1990 Jan; 35(1):55-60. PubMed ID: 2315370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum.
    Oh C; Gardiner TW; Rebec GV
    Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.